直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Chinese Audience Gets Bilski Breakdown

July 2, 2010

Managing Intellectual Property

The opening panel on day two of Managing IP’s China-International Forum considered patent prosecution and litigation in the US and was hosted by Finnegan, which represented Bilski before the Supreme Court. "It’s a tremendous victory for the patent bar and for patent owners who believe in the patentability of processes that do not fall within the three exceptions [laws of nature, physical phenomena and abstract ideas]," said Esther Lim, managing partner of Finnegan’s Shanghai office. Lim began the session by explaining Section 101 of the US Patent Act, the Court of Appeal for the Federal Circuit’s (CAFC’s) decisions in State Street and Bilski and the machine-or-transformation test. Richard Racine, managing partner at Finnegan, then outlined the basics of the Supreme Court’s decision. "The Supreme Court rejected the machine-or-transformation test as the sole or only test to determine patentability of a process under Section 101" he said. Racine added that there was "a big, collective sigh of relief" when patent practitioners learned that business methods would still be eligible for patent protection. Questions from the floor addressed the future of the machine-or-transformation test and whether patents should still be drafted with that test in mind. The consensus on the panel was that the safest course was to continue to draft claims to fit within that test.

Related Professionals

Richard B. Racine
高级顾问
Washington, DC
+1 202 408 4038
Email
林 艺 思
合伙人兼首席D&I执行官
Washington, DC
+1 202 408 4121
Email

Related News

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Commentary

Heartflow Accuses Rival of Building Competing AI Heart Tech on Stolen Secrets

April 23, 2026

Commentary

Litigation Leaders: Finnegan’s Jennifer Roscetti on the Advantages of Being Fully Focused on IP

April 6, 2026

Commentary

She Has a Point: Finnegan's Cora Holt

March 13, 2026

Commentary

Design Patent Dissent Highlights Frustration Over Subjectivity

February 11, 2026

Commentary

Rising Demand for Global IP Work Pushes Finnegan’s PEP Up Nearly 20%

January 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP